ProGo® proven to go beyond nutrition as it earns several new FDA structure function claims

ProGo® has cemented its status as a pure and proven nutritional ingredient after achieving a myriad of new US Food and Drug Administration (FDA) structure function claims.

HBC is pleased to announce that not only has ProGo® recently been recognised as a ‘New Dietary Ingredient’ (NDI) from the FDA – the highest safety rating and attestation available – but it has also achieved seven new FDA structure function claims. This latest announcement underlines ProGo®’s powerful antioxidant and anti-inflammatory properties. The natural collagen component has been shown to support the maintenance of optimal skin health and reduce wrinkles, whereas the peptides’ bioactivity can help promote energy and sustain overall health and wellbeing.

According to the FDA claims, ProGo® is proven to:

  • Help with dry skin
  • Reduce wrinkles and promote skin smoothness
  • Prevent an increase in trans-epidermal water loss
  • Reduce occasional fatigue and general feelings of occasional tiredness
  • Reduce oxidative stress caused by free radicals
  • Act as an antioxidant
  • Support skin health/appearance

Dr Crawford Currie, Head of R&D at Hofseth BioCare, explains what the latest claims mean for the nutraceutical market.

What makes ProGo® different from what is currently available on the market?

The peptides that constitute ProGo® provide not only nutritional benefits, such as collagen for skin health, but also deliver benefits beyond nutrition, including antioxidant effects to sustain overall health. The peptides achieve this by boosting natural defence systems used by the body to quench free radicals and protect the structural integrity of the body. This patented product possesses properties unique to the market, with unmatched claims and health benefits.

How do these claims underline HBC’s commitment to evidenced-based approach to supporting health and wellbeing?
At HBC, we believe it is important to scientifically characterise and demonstrate the health benefits that our products and ingredients deliver. Our health claims journey started with Qualified Health Claims (QHCs) in Canada, which found that ProGo® was the first and only non-iron product that could support healthy levels of iron in the blood and deliver antioxidant benefits for supporting overall health, as well as skin health. The structure function claims that we can now use in the US means that, across North America, we can communicate how our products can support health and wellbeing, in terms of skin and antioxidant health effects, as well as in promoting positive energy utilisation.

What do the latest FDA claims means for nutraceutical manufacturers?

The collagen market has become somewhat generic and uninspired. ProGo® offers fresh opportunities for the collagen supplementation market to innovate and deliver on the promise to consumers to provide products with purity-powered and potent antioxidant and energy benefits. Importantly, these health benefits are realised through the inherent bioactivity of the peptides: there are no antioxidants, naturally or added, in ProGo®. Rather, it’s the peptides themselves that help the body boost natural, antioxidant defence systems.

What’s most exciting about the science behind these new FDA claims?

We can now talk more fully to our science and its relevance to both beauty and healthy aging; we have a product that not only has claims for supporting skin health by providing collagen supplementation, but it can also protect the skin with its antioxidant benefits. Furthermore, ProGo® has been proven to help reduce occasional fatigue and general feelings of occasional tiredness. This is a really exciting set of claims, all substantiated by our research into the bioactive peptides in ProGo®. Ongoing studies are being conducted into the efficacy of these bioactive peptides in supporting immunity and gut health and its role as an effective weight management aid and we look forward to discovering the full potential of this naturally-inspired nutritional innovation.

A global leader in marine lipid and peptide research, HBC uses patent-protected hydrolysis technology to convert fresh sashimi-grade salmon byproducts into nutritional ingredients for the enhancement and advancement of human health.

HBC’s resourceful, tried and trusted, truly sustainable approach to nutrition is unrivalled, earning it numerous industry awards, most recently the Ringier Food & Beverage Industry - Raw Materials and Ingredients category Award 2022.

To discover more about Hofseth BioCare and its product portfolio, contact the team here: Hofseth BioCare | Research and development.